Molecules (2018)
Update date:2022-09-26
Topics:
Cai, Wenqing
Wu, Jingwei
Liu, Wei
Xie, Yafei
Liu, Yuqiang
Zhang, Shuo
Xu, Weiren
Tang, Lida
Wang, Jianwu
Zhao, Guilong
In order to systematically explore and better understand the structure-activity relationship (SAR) of a diarylmethane backbone in the design of potent uric acid transporter 1 (URAT1) inhibitors, 33 compounds (1a-1x and 1ha-1hi) were designed and synthesized, and their in vitro URAT1 inhibitory activities (IC50) were determined. The three-round systematic SAR exploration led to the discovery of a highly potent novel URAT1 inhibitor, 1h, which was 200-and 8-fold more potent than parent lesinurad and benzbromarone, respectively (IC50 = 0.035 μM against human URAT1 for 1h vs. 7.18 μM and 0.28 μM for lesinurad and benzbromarone, respectively). Compound 1h is the most potent URAT1 inhibitor discovered in our laboratories so far and also comparable to the most potent ones currently under development in clinical trials. The present study demonstrates that the diarylmethane backbone represents a very promising molecular scaffold for the design of potent URAT1 inhibitors.
View MoreTaizhou Huading Chemical Co.,Ltd
Contact:+86-576-88583898
Address:Economic&Technology development zone,Taizhou City,Zhejiang Province,China
Jiangsu Fengshan Group Co., Ltd.
Contact:86-25-86558671
Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Contact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
Contact:0833-5590788/5590338/5590055
Address:Victory in the town of Red Star Village,Mount Emei City,industrial concentration area storage processing logistics parkpark
Doi:10.1080/00397911.2020.1802759
(2020)Doi:10.1016/j.bmc.2016.12.013
(2017)Doi:10.1021/om00046a012
(1992)Doi:10.1016/j.tetlet.2013.04.064
(2013)Doi:10.1021/om4000538
(2013)Doi:10.3762/bjoc.9.48
(2013)